Review
Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jul 16, 2015; 3(7): 556-574
Published online Jul 16, 2015. doi: 10.12998/wjcc.v3.i7.556
From variome to phenome: Pathogenesis, diagnosis and management of ectopic mineralization disorders
Eva YG De Vilder, Olivier M Vanakker
Eva YG De Vilder, Olivier M Vanakker, Center for Medical Genetics, Ghent University Hospital, B-9000 Ghent, East Flanders, Belgium
Eva YG De Vilder, Department of Ophthalmology, Ghent University Hospital, B-9000 Ghent, East Flanders, Belgium
Author contributions: De Vilder EYG wrote the paper; Vanakker OM edited the paper.
Supported by The Research Foundation Flanders (FWO) (FWO14/ASP/084), Vanakker OM is a senior clinical investigator at the Fund for Scientific Research-Flanders; Contract grant sponsor: FWO grant No G.0241.11N and Methusalem grant No. 08/01M01108.
Conflict-of-interest statement: The authors declare no conflict of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Vanakker M Olivier, MD, PhD, Center for Medical Genetics, Ghent University Hospital, De Pintelaan 185, B-9000 Ghent, East Flanders, Belgium. olivier.vanakker@ugent.be
Telephone: +32-9-3323603 Fax: +32-9-3324970
Received: November 29, 2014
Peer-review started: November 29, 2014
First decision: February 7, 2015
Revised: February 27, 2015
Accepted: May 16, 2015
Article in press: May 18, 2015
Published online: July 16, 2015
Abstract

Ectopic mineralization - inappropriate biomineralization in soft tissues - is a frequent finding in physiological aging processes and several common disorders, which can be associated with significant morbidity and mortality. Further, pathologic mineralization is seen in several rare genetic disorders, which often present life-threatening phenotypes. These disorders are classified based on the mechanisms through which the mineralization occurs: metastatic or dystrophic calcification or ectopic ossification. Underlying mechanisms have been extensively studied, which resulted in several hypotheses regarding the etiology of mineralization in the extracellular matrix of soft tissue. These hypotheses include intracellular and extracellular mechanisms, such as the formation of matrix vesicles, aberrant osteogenic and chondrogenic signaling, apoptosis and oxidative stress. Though coherence between the different findings is not always clear, current insights have led to improvement of the diagnosis and management of ectopic mineralization patients, thus translating pathogenetic knowledge (variome) to the phenotype (phenome). In this review, we will focus on the clinical presentation, pathogenesis and management of primary genetic soft tissue mineralization disorders. As examples of dystrophic calcification disorders Pseudoxanthoma elasticum, Generalized arterial calcification of infancy, Keutel syndrome, Idiopathic basal ganglia calcification and Arterial calcification due to CD73 (NT5E) deficiency will be discussed. Hyperphosphatemic familial tumoral calcinosis will be reviewed as an example of mineralization disorders caused by metastatic calcification.

Keywords: Ectopic mineralization, Pseudoxanthoma elasticum, Pseudoxanthoma elasticum-like syndrome, Generalized arterial calcification of infancy, Keutel syndrome, Idiopathic basal ganglia calcification, Arterial calcification due to CD73 deficiency, Hyperphosphatemic familial tumoral calcinosis, Etiology, Phenotype

Core tip: Ectopic mineralization disorders represent a broad range of phenotypically heterogenous diseases, often leading to significant morbidity and mortality. Involving a complex interplay between different pro-osteogenic mediators and inhibitors of calcification, the mechanisms of ectopic mineralization are progressively being unveiled. Though current knowledge is beyond any doubt the tip of the proverbial iceberg, insights already have significant implications in the diagnosis and daily management of these patients. As such, ectopic mineralization diseases are a fine example of translating variome data to the clinic. Here, we will discuss prototype hereditary ectopic calcification diseases with respect to their presentation, diagnosis and management.